Form D · Pharmaceuticals

Perosphere Inc.

Danbury, CT · CIK 0001539923

Offering snapshot reported Feb 4, 2016 · SEC filing

Reported sold: $6.21M
Investors reported: 42
Minimum accepted: $30K
First sale: Oct 8, 2015

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$2,123,355 → $6,212,355
Reported investors28 → 42

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Feb 4, 2016	Amendment	$6,212,355	$4,089,000vs Oct 23, 2015	42	SEC filing
Oct 23, 2015	Initial	$2,123,355	No comparison	28	SEC filing
Jan 18, 2012	Initial	$1,034,124	No comparison	20	SEC filing

Offering details

Securities: Equity, Other
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-249993

Series B Preferred Stock convertible into Common Stock

Source: Form D, filed Feb 4, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Sasha H. Bakhru	Executive
James C. Costin	Executive
Bryan E. Laulicht	Executive
Edith Mathiowitz	Director, Executive
Andreas Pfutzner	Director
Solomon S. Steiner	Director, Executive
Charles A. Steiner	Director
Erik Steiner	Executive
Philip N. Sussman	Executive
Peter Van Straelen	Executive
R. Timmis Ware	Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

20 Kenosia Avenue
Danbury, CT, 06810